In a surprising turn of events, Paramount Global recently announced its decision to effectively dismantle several of its diversity, equity, and inclusion (DEI) initiatives. This development raises questions about the future landscape of corporate practices in relation to DEI efforts. The media giant’s announcement was detailed in a memo to employees, acquired by CNBC. In
Business
General Motors (GM) is making significant financial maneuvers to bolster its standing amid a challenging automotive market. In a notable announcement, the company revealed a 25% increase in its quarterly dividend, elevating it to 15 cents per share. This decision is not only a move to reward shareholders but also a strategic response to the
Eli Lilly has recently taken significant steps to address the challenges faced by patients seeking access to its weight loss drug, Zepbound. With growing demand, particularly from individuals who lack adequate insurance coverage, including many Medicare beneficiaries, Eli Lilly aims to provide more affordable options. This initiative not only expands the availability of this effective
In the evolving landscape of American governance, influential voices such as Jamie Dimon, the CEO of JPMorgan Chase, have begun to critically assess the effectiveness of federal operations. During a recent interview with CNBC’s Leslie Picker, Dimon highlighted considerable inefficiencies within the U.S. government, prompting a larger conversation about the necessary reforms in public administration.
As the largest private health insurer in the United States, UnitedHealthcare is frequently at the forefront of healthcare discussions. However, recent developments have prompted significant scrutiny of the giant’s practices and strategies. From an ongoing government investigation into its Medicare billing practices to employee buyouts and the company’s public squabbles with influential investors, the past
The recent announcement by the U.S. Food and Drug Administration (FDA) has significant ramifications for both the prescription drug market and patients who rely on semaglutide treatments like Wegovy, designed for weight loss, and Ozempic, formulated for diabetes management. The resolution of the semaglutide shortage, which has persisted for over two years, presents a multifaceted
The biotech sector is often touted as the frontier of medical innovation, with companies like Bluebird Bio once standing out as beacons of hope in the battle against genetic disorders. However, the announcement of Bluebird Bio’s acquisition by private equity firms Carlyle and SK Capital for approximately $30 million encapsulates the dramatic fall from grace
In the realm of aviation and presidential logistics, few symbols are as significant as Air Force One. President Donald Trump’s recent expressions of dissatisfaction regarding the production timeline of two new Boeing 747s, designated to serve as the next iterations of this iconic aircraft, have illuminated ongoing challenges within the aerospace industry. Originally slated for
Sickle cell disease (SCD) remains a critical health issue, particularly within vulnerable communities such as African Americans. Patients like Deshawn “DJ” Chow exemplify the struggles faced by those living with the condition. Having battled debilitating pain since his early teens, Chow’s journey takes a hopeful turn with the advent of new gene therapies, yet it
KFC, the iconic fried chicken chain that rooted itself in the heart of Kentucky, has announced a significant organizational shift by relocating its U.S. headquarters from Louisville to Plano, Texas. This move, disclosed by Yum Brands on Tuesday, isn’t merely logistical but rather a calculated strategic decision that reflects a larger trend among corporations reassessing